Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multidrug-resistant tuberculosis--can the tide be turned?

A Zumla1, J M Grange

  • 1Centre for Infectious Diseases and International Health, Royal Free and University College Medical School, Windeyer Institute for Medical Science, London, UK. a.zumla@ucl.ac.uk

The Lancet. Infectious Diseases
|March 2, 2002
PubMed
Summary

Tuberculosis (TB) is increasing globally, posing a significant health threat. A concerning rise in multidrug-resistant TB cases, resistant to isoniazid and rifampicin, complicates treatment efforts worldwide.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Drug management of TB in the intensive care setting: an international multicentre study.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2025
Same author

The WHO mpox public health emergency of international concern declaration: Need for reprioritisation of global public health responses to combat the MPXV Clade I epidemic.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2024
Same author

Vaccination for monkeypox prevention in persons with high-risk sexual behaviours to control on-going outbreak of monkeypox virus clade 3.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2022
Same author

The war in Ukraine and potential consequences for the TB epidemic in Europe.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2022
Same author

Comparison of patients with severe COVID-19 admitted to an intensive care unit in South Africa during the first and second wave of the COVID-19 pandemic.

African journal of thoracic and critical care medicine·2022
Same author

Xpert® MTB/RIF assay testing on stool for the diagnosis of paediatric pulmonary TB in Tanzania.

Public health action·2021

Area of Science:

  • Public Health
  • Infectious Diseases
  • Microbiology

Background:

  • Tuberculosis (TB) remains a critical global health challenge, with increasing incidence worldwide.
  • Control efforts have been challenged by the growing prevalence of the disease.
  • A significant rise in drug-resistant TB strains is a major concern.

Purpose of the Study:

  • To highlight the escalating global burden of tuberculosis.
  • To emphasize the increasing threat of multidrug-resistant tuberculosis (MDR-TB).
  • To underscore the resistance to key antituberculosis drugs: isoniazid and rifampicin.

Main Methods:

  • Review of global tuberculosis incidence data.
  • Analysis of trends in drug resistance patterns.
  • Focus on resistance to isoniazid and rifampicin.

Related Experiment Videos

Main Results:

  • Global tuberculosis cases are at an all-time high.
  • There is a notable increase in multidrug-resistant tuberculosis (MDR-TB) cases.
  • Resistance to isoniazid and rifampicin is a primary driver of MDR-TB.

Conclusions:

  • Continued and intensified global efforts are needed to combat the rising tide of tuberculosis.
  • Addressing multidrug resistance is paramount for effective tuberculosis control.
  • Urgent strategies are required to manage and treat drug-resistant tuberculosis strains.